KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Baxter International (BAX) EBITDA (2016 - 2024)

Historic EBITDA for Baxter International (BAX) over the last 16 years, with Q4 2024 value amounting to $959.0 million.

  • Baxter International's EBITDA rose 4845.2% to $959.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 billion, marking a year-over-year increase of 35403.11%. This contributed to the annual value of -$308.0 million for FY2025, which is 230000.0% down from last year.
  • As of Q4 2024, Baxter International's EBITDA stood at $959.0 million, which was up 4845.2% from $1.0 billion recorded in Q3 2024.
  • In the past 5 years, Baxter International's EBITDA ranged from a high of $1.0 billion in Q3 2024 and a low of -$2.9 billion during Q3 2022
  • Moreover, its 5-year median value for EBITDA was $360.5 million (2020), whereas its average is $205.9 million.
  • In the last 5 years, Baxter International's EBITDA tumbled by 145652.17% in 2022 and then skyrocketed by 616470.59% in 2024.
  • Quarter analysis of 5 years shows Baxter International's EBITDA stood at $406.0 million in 2020, then tumbled by 94.33% to $23.0 million in 2021, then crashed by 1456.52% to -$312.0 million in 2022, then skyrocketed by 307.05% to $646.0 million in 2023, then surged by 48.45% to $959.0 million in 2024.
  • Its EBITDA stands at $959.0 million for Q4 2024, versus $1.0 billion for Q3 2024 and $1.0 billion for Q2 2024.